Samsung Pharm (001360) — Cash Flow Reinvestment Rate
Samsung Pharm (001360) has a Cash Flow Reinvestment Rate of 0.48x as of June 2022, reinvesting ₩766.26 Million (capex ₩638.30 Million plus investments ₩-127.95 Million) from operating cash flow of ₩1.59 Billion. See 001360 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Samsung Pharm Cash Flow Reinvestment Rate (2017–2017)
Historical reinvestment intensity for Samsung Pharm across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does Samsung Pharm generate cash.
Annual Cash Flow Reinvestment Rate for Samsung Pharm (2017–2017)
Year-by-year capital reinvestment analysis for Samsung Pharm. See 001360 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 1.26x | ₩6.51 Billion | ₩5.15 Billion | ₩6.11 Billion | — |